{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:25:38Z","timestamp":1778621138438,"version":"3.51.4"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fonds Sp\u00e9ciaux pour la Recherche Facultaires","award":["3328"],"award-info":[{"award-number":["3328"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Regenerative therapy for bladder diseases has been studied in rodent to restore bladder function after a chronic and irreversible bladder wall deterioration. These studies rarely demonstrate the presence of stem cells in the bladder. Cell-tracking after intravenous (IV) administration of stem cells enables to confirm the homing potential of an injury. Our objective was to assess, in one dog, the homing capability of autologous adipose-derived mesenchymal stromal\/stem cells (ADMSCs) injected intravenously to an acute bladder injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adipose-derived mesenchymal stromal\/stem cells were isolated from the subcutaneous tissue of a dog and labelled. As a homing signal, a full-thickness bladder biopsy representing an acute injury was created in this dog (day 0, control time). Twenty million autologous PKH26-labelled ADMSCs were injected in the cephalic vein on days 1, 4 and 8. Urinalysis was performed (day 5). Bladder biopsy was repeated at the location of the previous scar to assess the presence of labelled ADMSCs in the bladder wall (day 10).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Labelled ADMSCs were observed in the second bladder biopsy, not in the initial biopsy nor in urine. The only adverse event mild, self-limiting hematuria. Complete cell blood count, blood urea nitrogen and plasma creatinine were within normal limits (day 5).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The comparison of bladder biopsies before and after IV administration of autologous ADMSCs indicates that they reached the bladder injury. Our protocol was feasible and safe. Hematuria was probably due to the bladder biopsy. These results could encourage the evaluation of this protocol in larger cohorts of dogs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2025.1644746","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:24:40Z","timestamp":1764948280000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tracking of autologous adipose-derived mesenchymal stromal\/stem cells after intravenous administration: a pilot study in a dog with induced acute bladder injury"],"prefix":"10.3389","volume":"12","author":[{"given":"Mathilde","family":"Porato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Waroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00eblle","family":"Piret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Hamaide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.5213\/inj.1836014.007","article-title":"The therapeutic effect of human embryonic stem cell-derived multipotent mesenchymal stem cells on chemical-induced cystitis in rats","volume":"22","author":"Lee","year":"2018","journal-title":"Int Neurourol J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.7150\/thno.27559","article-title":"Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis\/bladder pain syndrome","volume":"8","author":"Ryu","year":"2018","journal-title":"Theranostics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.juro.2011.11.079","article-title":"Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease","volume":"187","author":"Soler","year":"2012","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2019.02.011","article-title":"Intra-bladder wall transplantation of bone marrow mesenchymal stem cells improved urinary bladder dysfunction following spinal cord injury","volume":"221","author":"Salehi-pourmehr","year":"2019","journal-title":"Life Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.5489\/cuaj.3257","article-title":"Benefits of mesenchymal stem cells after partial bladder outlet obstruction","volume":"10","author":"Al-Saikan","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"110572","DOI":"10.1016\/j.mehy.2021.110572","article-title":"Hypothesis: intravenous administration of mesenchymal stem cells is effective in the treatment of Alzheimer\u2019s disease","volume":"150","author":"Shigematsu","year":"2021","journal-title":"Med Hypotheses"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: the devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/molecules28031165","article-title":"Heavily Gd-doped non-toxic cerium oxide nanoparticles for MRI labelling of stem cells","volume":"28","author":"Popov","year":"2023","journal-title":"Molecules"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13287-019-1296-8","article-title":"Labeling of human mesenchymal stem cells with different classes of vital stains: robustness and toxicity","volume":"10","author":"Andrzejewska","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-011-0712-x","article-title":"Adipose derived stem cells: efficiency, toxicity, stability of BrdU labeling and effects on self-renewal and adipose differentiation","volume":"351","author":"Lequeux","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.105.537480","article-title":"Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction","volume":"112","author":"Kraitchman","year":"2005","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.1002\/chem.200901548","article-title":"Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles","volume":"15","author":"Wang","year":"2009","journal-title":"Chem Eur J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4142\/jvs.2009.10.4.273","article-title":"Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury","volume":"10","author":"Ryu","year":"2009","journal-title":"J Vet Sci"},{"key":"ref14","first-page":"275","article-title":"Homing and efficacy of intra-articular injection of autologous mesenchymal stem cells in experimental chondral defects in dogs","volume":"29","author":"Mokbel","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.hlc.2008.01.006","article-title":"Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent dye tracking","volume":"17","author":"Weir","year":"2008","journal-title":"Heart Lung Circ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tice.2012.02.001","article-title":"Bone marrow and adipose stem cells can be tracked with PKH26 until post staining passage 6 in in vitro and in vivo","volume":"44","author":"Ude","year":"2012","journal-title":"Tissue Cell"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10616-017-0097-0","article-title":"Evaluation of persistence and distribution of intra-dermally administered PKH26 labelled goat bone marrow derived mesenchymal stem cells in cutaneous wound healing model","volume":"69","author":"Pratheesh","year":"2017","journal-title":"Cytotechnology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0039-1678547","article-title":"Evaluation of intravenously delivered allogeneic mesenchymal stem cells for treatment of elbow osteoarthritis in dogs: a pilot study","volume":"32","author":"Olsen","year":"2019","journal-title":"Vet Comp Orthop Traumatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.14202\/vetworld.2016.1429-1434","article-title":"Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease","volume":"9","author":"Petchdee","year":"2016","journal-title":"Vet World"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1751-0147-56-16","article-title":"Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation","volume":"56","author":"Kang","year":"2014","journal-title":"Acta Vet Scand"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13287-015-0240-9","article-title":"The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12015-020-10040-7","article-title":"Immunosuppressive effects of mesenchymal stem cells-derived exosomes","volume":"17","author":"Qian","year":"2021","journal-title":"Stem Cell Rev Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/tan.12614","article-title":"Allogenic benefit in stem cell therapy: cardiac repair and regeneration","volume":"86","author":"Al-Daccak","year":"2015","journal-title":"Tissue Antigens"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5830103","article-title":"Allogeneic mesenchymal stem cell treatment induces specific alloantibodies in horses","volume":"2016","author":"Owens","year":"2016","journal-title":"Stem Cells Int"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13287-017-0742-8","article-title":"Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells","volume":"8","author":"Berglund","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41408-023-00900-z","article-title":"Long-term outcomes of allogeneic stem cell transplant in multiple myeloma","volume":"13","author":"Schmidt","year":"2023","journal-title":"Blood Cancer J"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.3390\/jcm13206207","article-title":"Impact of allogeneic stem cell transplant on safety and outcomes of chimeric antigen receptor T cell (CAR-T) therapy in patients with multiple myeloma (MM)","volume":"13","author":"Bangolo","year":"2024","journal-title":"J Clin Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1402106","DOI":"10.3389\/fonc.2024.1402106","article-title":"Allogeneic stem cell transplantation in multiple myeloma: is there still a place?","volume":"14","author":"Liberatore","year":"2024","journal-title":"Front Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1038\/bcj.2011.14","article-title":"Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update","volume":"1","author":"Mohty","year":"2011","journal-title":"Blood Cancer J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13287-017-0503-8","article-title":"Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model","volume":"8","author":"Joswig","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/evj.13136","article-title":"Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: clinical and cytological comparisons suggest safety","volume":"52","author":"Colbath","year":"2020","journal-title":"Equine Vet J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"899666","DOI":"10.3389\/fimmu.2022.899666","article-title":"Clinical evaluation of autologous and allogeneic stem cell therapy for intrauterine adhesions: a systematic review and meta-analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/scrt72","article-title":"Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells","volume":"2","author":"Gharaibeh","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1089\/scd.2013.0277","article-title":"The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder","volume":"23","author":"Song","year":"2014","journal-title":"Stem Cells Dev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell Secretome: toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.vetimm.2018.12.003","article-title":"Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species","volume":"208","author":"Villatoro","year":"2019","journal-title":"Vet Immunol Immunopathol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13287-015-0250-7","article-title":"Tissues from equine cadaver ligaments up to 72 hours of post-mortem: a promising reservoir of stem cells","volume":"6","author":"Shikh Alsook","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1746-6148-8-150","article-title":"Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells","volume":"8","author":"Takemitsu","year":"2012","journal-title":"BMC Vet Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2460\/ajvr.73.8.1305","article-title":"Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum","volume":"73","author":"Kisiel","year":"2012","journal-title":"Am J Vet Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3727\/096368909X481764","article-title":"Isolation, characterization, and differentiation potential of canine adipose-derived stem cells","volume":"19","author":"Vieira","year":"2010","journal-title":"Cell Transplant"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/stem.2377","article-title":"Concise review: stem cell trials using companion animal disease models","volume":"34","author":"Hoffman","year":"2016","journal-title":"Stem Cells"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3727\/096368911X576036","article-title":"Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression","volume":"21","author":"Lundberg","year":"2012","journal-title":"Cell Transplant"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/ijms17060982","article-title":"Strategies to optimize adult stem cell therapy for tissue regeneration","volume":"17","author":"Liu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","journal-title":"Stem Cells Dev"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2863501","article-title":"Multiple intravenous injections of valproic acid-induced mesenchymal stem cell from human-induced pluripotent stem cells improved cardiac function in an acute myocardial infarction rat model","volume":"2020","author":"Guo","year":"2020","journal-title":"Biomed Res Int"},{"key":"ref48","first-page":"E1","article-title":"Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study","volume":"11","author":"Hall","year":"2010","journal-title":"Vet Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.26355\/eurrev_201909_18877","article-title":"Intravenous stem cell dose and changes in quantitative lung fibrosis and DLCO in the AETHER trial: a pilot study","volume":"23","author":"Fishman","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13287-015-0236-5","article-title":"Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury","volume":"6","author":"Kim","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4172\/2157-7552.1000199","article-title":"Labeling mesenchymal stromal cells with PKH26 or VybrantDil significantly diminishes their migration, but does not affect their viability, attachment, proliferation and differentiation capacities","volume":"8","author":"Kelp","year":"2017","journal-title":"J Tissue Sci Eng"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","article-title":"Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy","volume":"66","author":"Karantalis","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/vru.12243","article-title":"Scintigraphic tracking of mesenchymal stem cells after portal, systemic, intravenous and splenic adminstration in healthy beagle dogs","volume":"56","author":"Spriet","year":"2015","journal-title":"Vet Radiol Ultrasound"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/ten.tec.2011.0275","article-title":"Long-term detection of fluorescently labeled human mesenchymal stem cell in vitro and in vivo by semi-automated microscopy","volume":"18","author":"Polzer","year":"2012","journal-title":"Tissue Eng Part C Methods"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: time to change the name!","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/scd.2010.0466","article-title":"Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans","volume":"20","author":"Ra","year":"2011","journal-title":"Stem Cells Dev"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1292\/jvms.20-0195","article-title":"Efficacy and safety of allogenic canine adipose tissue-derived mesenchymal stem cell therapy for insulin-dependent diabetes mellitus in four dogs: a pilot study","volume":"83","author":"Rhew","year":"2021","journal-title":"J Vet Med Sci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12917-021-02791-3","article-title":"Manufacturing and banking canine adipose-derived mesenchymal stem cells for veterinary clinical application","volume":"17","author":"Luo","year":"2021","journal-title":"BMC Vet Res"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tvjl.2015.07.023","article-title":"Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: endoscopic and histological outcomes","volume":"206","author":"P\u00e9rez-Merino","year":"2015","journal-title":"Vet J"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4111\/kju.2014.55.4.228","article-title":"Treatment of bladder dysfunction using stem cell or tissue engineering technique","volume":"55","author":"Kim","year":"2014","journal-title":"Korean J Urol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","article-title":"Use of mesenchymal stem cells for therapy of cardiac disease","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ Res"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/14653240310003026","article-title":"Adipose-derived adult stem cells: isolation, characterization, and differentiation potential","volume":"5","author":"Gimble","year":"2003","journal-title":"Cytotherapy"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCRESAHA.116.310342","article-title":"Is there a role for intravenous stem cell delivery in nonischemic cardiomyopathy?","volume":"120","author":"Traverse","year":"2017","journal-title":"Circ Res"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.rvsc.2010.07.024","article-title":"Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation","volume":"91","author":"Martinello","year":"2011","journal-title":"Res Vet Sci"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12015-012-9397-0","article-title":"Effect of anatomical origin and cell passage number on the stemness and osteogenic differentiation potential of canine adipose-derived stem cells","volume":"8","author":"Requicha","year":"2012","journal-title":"Stem Cell Rev Rep"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"O28","DOI":"10.1111\/vsu.13267","article-title":"Isolation of canine adipose-derived mesenchymal stem cells from falciform tissue obtained via laparoscopic morcellation: a pilot study","volume":"49","author":"DePompeo","year":"2020","journal-title":"Vet Surg"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1644746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:24:42Z","timestamp":1764948282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1644746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":68,"alternative-id":["10.3389\/fvets.2025.1644746"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1644746","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"article-number":"1644746"}}